Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-12-30 Sale | 2023-01-03 4:45 pm | Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO | 19,582 | $45.57 | $892,352 | 2,824,385 (Indirect Direct) | View |
| 2021-05-03 Sale | 2021-05-05 11:32 am | Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO | 30,000 | $107.8 | $3,234,000 | 2,855,793 (Indirect Direct) | View |
| 2021-03-01 Sale | 2021-03-03 8:36 pm | Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO | 30,000 | $141.8 | $4,254,000 | 2,921,793 (Indirect Direct) | View |
| 2021-01-04 Sale | 2021-01-05 6:45 pm | Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO | 30,000 | $136.9 | $4,107,000 | 2,939,930 (Indirect Direct) | View |
| 2020-11-02 Sale | 2020-11-04 3:44 pm | Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO | 30,000 | $96.82 | $2,904,600 | 2,969,930 (Indirect Direct) | View |
| 2020-09-01 Sale | 2020-09-02 4:26 pm | Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO | 30,000 | $82.63 | $2,478,900 | 3,000,782 (Indirect Direct) | View |
| 2020-07-13 Sale | 2020-07-15 1:22 pm | Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO | 40,000 | $85.35 | $3,414,000 | 3,030,782 (Indirect Direct) | View |
| 2019-09-11 Purchase | 2019-09-11 12:35 pm | Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO | 5,000 | $43.63 | $218,150 | 3,032,220 (Indirect Direct) | View |
| 2019-03-01 Sale(A) | 2019-04-17 5:38 pm | Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO | 2,890 | $65.52 | $189,353 | 3,093,324 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-03-01 Tax Withholding | 2022-03-03 6:06 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO | 12,162 | $67.37 | 2,936,327 (Direct) | View |
| 2022-03-01 Option Award | 2022-03-03 6:06 pm | N/A 2032-03-01 | Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO | 144,401 | $0 | 2,936,327 (Direct) | View |
| 2021-12-31 Ownership | 2022-02-01 1:41 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO | 0 | $0 | 2,804,088 (Direct) | View |
| 2021-12-31 Ownership | 2022-02-01 1:41 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO | 50,000 | $0 | 2,804,088 (Indirect) | View |
| 2021-10-14 Tax Withholding | 2021-10-18 6:44 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO | 853 | $81 | 2,854,088 (Direct) | View |
| 2021-05-06 Tax Withholding | 2021-05-10 6:11 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO | 852 | $115.71 | 2,854,941 (Direct) | View |
| 2021-03-01 Tax Withholding | 2021-03-03 8:36 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO | 16,342 | $142.47 | 2,921,793 (Direct) | View |
| 2021-03-01 Option Award | 2021-03-03 8:36 pm | N/A 2031-03-01 | Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO | 69,453 | $0 | 2,921,793 (Direct) | View |
| 2020-12-31 Ownership | 2021-02-03 8:03 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO | 181,670 | $0 | 2,928,682 (Indirect) | View |
| 2020-10-14 Tax Withholding | 2020-10-16 7:23 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO | 852 | $92.69 | 2,999,930 (Direct) | View |
| 2020-06-01 Tax Withholding | 2020-06-03 2:17 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO | 1,334 | $69.38 | 3,070,782 (Direct) | View |
| 2020-05-06 Tax Withholding | 2020-05-08 8:06 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO | 852 | $66.26 | 3,212,538 (Direct) | View |
| 2020-04-19 Tax Withholding | 2020-04-21 3:34 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO | 851 | $58.57 | 3,213,390 (Direct) | View |
| 2020-03-12 Exercise | 2020-03-13 12:59 pm | 2010-06-30 2020-06-30 | Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO | 149,700 | $0 | 3,214,241 (Direct) | View |
| 2020-03-12 Exercise | 2020-03-13 12:59 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO | 149,700 | $3.006 | 3,214,241 (Direct) | View |
| 2020-03-01 Option Award | 2020-03-03 7:58 pm | N/A 2030-03-01 | Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO | 91,882 | $0 | 3,120,641 (Direct) | View |
| 2020-03-01 Tax Withholding | 2020-03-03 7:58 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO | 6,896 | $56.08 | 3,120,641 (Direct) | View |
| 2019-10-14 Option Award | 2019-10-16 7:30 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO | 3,435 | $0 | 3,035,655 (Direct) | View |
| 2019-06-01 Tax Withholding | 2019-06-04 6:59 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO | 1,327 | $54.93 | 3,027,220 (Direct) | View |
| 2019-05-21 Tax Withholding | 2019-05-22 5:44 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO | 1,414 | $59.5 | 3,028,547 (Direct) | View |
| 2019-05-06 Option Award | 2019-05-07 6:57 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO | 3,435 | $0 | 3,029,961 (Direct) | View |
| 2019-04-19 Tax Withholding | 2019-04-23 6:41 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO | 798 | $64.43 | 3,026,526 (Direct) | View |
| 2019-03-01(A) Option Award | 2019-04-17 5:38 pm | N/A 2029-03-01 | Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO | 86,000 | $0 | 3,093,324 (Direct) | View |
| 2019-03-01 Tax Withholding | 2019-03-04 5:00 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO | 2,802 | $67.55 | 3,093,411 (Direct) | View |
| 2019-03-01 Option Award | 2019-03-04 5:00 pm | N/A 2029-03-01 | Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO | 86,000 | $0 | 3,093,411 (Direct) | View |
| 2018-06-01 Tax Withholding | 2018-06-04 4:45 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO | 926 | $73.73 | 3,010,213 (Direct) | View |
| 2018-05-21 Tax Withholding | 2018-05-22 11:42 am | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO | 986 | $64.79 | 3,011,139 (Direct) | View |
| 2018-04-19 Option Award | 2018-04-19 4:42 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO | 3,429 | $0 | 3,012,125 (Direct) | View |
| 2018-03-01 Tax Withholding | 2018-03-05 4:12 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO | 1,114 | $48.43 | 3,103,196 (Direct) | View |
| 2018-03-01 Option Award | 2018-03-05 4:12 pm | N/A 2028-03-01 | Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO | 114,000 | $0 | 3,103,196 (Direct) | View |